自组装的抗氧化纳米颗粒增加生存率并减少严重疟疾的疾病症状
Toru Yoshitomi1,2,3, Kyoko Hayashi4, Tamasa Araki5,6
1Research Center for Macromolecules and Biomaterials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.
Molecular pharmaceutics
|September 13, 2025
概括
氧化纳米颗粒 (RNPs) 有效地对抗疟疾等传染病中的氧化应激. 这些新型纳米粒子减少反应性氧物种 (ROS) 并改善生存率,提供了一个有前途的治疗方法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 严重的感染会导致细胞因子风暴和过度反应性氧物种 (ROS),导致细胞损伤.
- 传统的低分子量 (LMW) 抗氧化剂对感染诱导的氧化应激无效,原因是快速清除和细胞氧化还原平衡的潜在破坏.
- 一种新型的自我组装抗氧化纳米粒子,称为氧化还原纳米粒子 (RNP),被开发来克服LMW抗氧化剂的限制.
研究的目的:
- 评估RNP在减轻氧化应激和改善传染病模型结果中的有效性.
- 评估RNP的药理动力学特征及其对细胞损伤和存活的影响.
主要方法:
- 开发一种具有聚乙烯糖外的自组装抗氧化纳米粒子 (RNP).
- 在一只 Plasmodium berghei 诱导的疟疾小鼠模型中对 RNP 的评估.
- 测量ROS水平,红细胞膜完整性,疾病严重程度和生存率.
主要成果:
- 在给药后,RNP显示持续循环 (>24小时).
- 与未经治疗的对照和LMW TEMPOL相比,RNP显著降低了疟疾感染小鼠的ROS水平.
- RNP治疗改善了疾病的严重程度,提高了存活率,并保护了红细胞膜免受氧化损伤.
结论:
- 在传染病中,RNP是一种强大的治疗剂,用于控制感染性疾病中的氧化应激.
- RNP的独特特性,包括有针对性的作用和保存的氧化还原平衡,比传统的抗氧化剂提供了显著的优势.
- RNP显示出作为疟疾和其他与氧化压力相关的传染病的突破性治疗的潜力.
相关概念视频
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...